Literature DB >> 17332739

The prevalence and incidence of end-stage renal disease in Native American adults on the Navajo reservation.

M E Hochman1, J P Watt, R Reid, K L O'Brien.   

Abstract

Whereas members of the Navajo Nation are at high risk for diabetes mellitus, there are no recent published estimates of the burden of end-stage renal disease (ESRD), an important sequela of diabetes, on the Navajo Nation, a 16 million acre area in Arizona, New Mexico, and Utah with more than 200 000 tribal members. We used data from the US Renal Data System to estimate the prevalence and incidence of ESRD among Native American adults (>/=18 years) living on the Navajo Nation. For comparison, we estimated the prevalence and incidence of ESRD among all adults in the US, all Native American adults in the US, and Native American adults living in Arizona, New Mexico, Utah, and Colorado excluding those living on the Navajo Nation. The age-adjusted prevalence of ESRD in the Native American adults on the Navajo Nation was 0.63%, which was higher than in the US adults (0.19%, P<0.0001) and among the Native American adults in the US (0.36%, P<0.0001), but lower than among the other Native American adults in the Southwest (0.89%, P<0.0001). The age-adjusted incidence of ESRD in the Native American adults on the Navajo Nation was 0.11%, which was also higher than in the US adults (0.045%, P<0.0001) and among the Native American adults in the US (0.073%, P<0.0009), but lower than among the other Native American adults in the Southwest (0.17%, P<0.0003). The reasons behind these disparities merit further study.

Entities:  

Mesh:

Year:  2007        PMID: 17332739     DOI: 10.1038/sj.ki.5002100

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress.

Authors:  Malou Friederich-Persson; Erik Thörn; Peter Hansell; Masaomi Nangaku; Max Levin; Fredrik Palm
Journal:  Hypertension       Date:  2013-09-09       Impact factor: 10.190

2.  Health-Related Quality of Life in End-Stage Renal Disease Patients and Healthy Individuals.

Authors:  Niyan Hakeem Ismael; Aso Omer Rashid
Journal:  Galen Med J       Date:  2020-12-29

Review 3.  Hypoxia: The Force that Drives Chronic Kidney Disease.

Authors:  Qiangwei Fu; Sean P Colgan; Carl Simon Shelley
Journal:  Clin Med Res       Date:  2016-02-04

4.  Hyperbaric oxygen therapy reduces renal lactate production.

Authors:  Thomas S Nørlinger; Per Mose Nielsen; Haiyun Qi; Emmeli Mikkelsen; Kasper Hansen; Nikolaj H Schmidt; Michael Pedersen; Peter Agger; Fredrik Palm; Christoffer Laustsen
Journal:  Physiol Rep       Date:  2017-03

Review 5.  Mitochondrial Reactive Oxygen Species and Kidney Hypoxia in the Development of Diabetic Nephropathy.

Authors:  Tomas A Schiffer; Malou Friederich-Persson
Journal:  Front Physiol       Date:  2017-04-11       Impact factor: 4.566

6.  Clinicopathological features of pediatric renal biopsies in the plateau regions of China.

Authors:  Nini Wang; Tingting Zhu; Yuhong Tao
Journal:  J Int Med Res       Date:  2018-07-20       Impact factor: 1.671

7.  Development of risk maps to minimize uranium exposures in the Navajo Churchrock mining district.

Authors:  Jamie L deLemos; Doug Brugge; Miranda Cajero; Mallery Downs; John L Durant; Christine M George; Sarah Henio-Adeky; Teddy Nez; Thomas Manning; Tommy Rock; Bess Seschillie; Chris Shuey; Johnnye Lewis
Journal:  Environ Health       Date:  2009-07-09       Impact factor: 5.984

8.  Reported sources of health inequities in Indigenous Peoples with chronic kidney disease: a systematic review of quantitative studies.

Authors:  Tania Huria; Suzanne G Pitama; Lutz Beckert; Jaquelyne Hughes; Nathan Monk; Cameron Lacey; Suetonia C Palmer
Journal:  BMC Public Health       Date:  2021-07-23       Impact factor: 3.295

9.  Does losartan prevent progression of early diabetic nephropathy in American Indians with type 2 diabetes?

Authors:  Susanne B Nicholas; Sudha K Iyengar
Journal:  Diabetes       Date:  2013-09       Impact factor: 9.461

Review 10.  Health risk of travel for chronic kidney disease patients.

Authors:  Yoshitaka Furuto; Mariko Kawamura; Akio Namikawa; Hiroko Takahashi; Yuko Shibuya
Journal:  J Res Med Sci       Date:  2020-03-18       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.